In the present study, we determined the effects of SARS-CoV-2 infection on the expression of TPH2, the rate-limiting enzyme of serotonin, which is closely associated with neuropsychiatric symptoms, such as depression, as well as its effects on nerve damage. Here, TPH2 is linked to depressive symptom measurement.